<?xml version="1.0" encoding="UTF-8"?>
<p>Overall, our results revealed novel mechanisms underlying changes in cDC generation in the context of influenza infection, and suggested that Flt3-L is a potential prognostic marker of susceptibility to secondary infections. Our results also highlighted the potential therapeutic value of Flt3-L in secondary bacterial infections; for example, combining Flt3-L with other growth factors and/or conventional antibacterial drugs (
 <italic>i</italic>.
 <italic>e</italic>. antibiotics) might increase therapeutic effectiveness.
</p>
